| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa131935c81c05eca0739bee387bd586
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bac8274280845763c67c5f53fb5c068a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84a91081c999420fa6c5778daa84b6c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c29178fceeed66c2b3569f4ded384ce0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-828
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91591 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-915
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-89 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-915 |
| filingDate |
2012-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61e34780fa7a40c50f3acc742c0bc3a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79925106e706f09ebf2a7032273e559e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa377130fd9f866823cd4ecc0ecebdb0 |
| publicationDate |
2015-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9220615-B2 |
| titleOfInvention |
Stent having at least one connecting member configured to controllably sever in vivo |
| abstract |
A stent may include a connector having a first portion, a second portion, and a third portion positioned between the first and second portions. The connector may be configured to interconnect axially adjacent stent segments. The connector may be further configured such that the third portion severs in response to a threshold amount of axial force, axial foreshortening, and/or cyclic loading or fatigue, in order to predispose the severance of one or more pre-configured connectors in a controlled manner to minimize any potential harm to the surrounding vasculature of a patient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11484422-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10767032-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11628075-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11298218-B2 |
| priorityDate |
2011-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |